Average Co-Inventor Count = 4.91
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (22 from 2,405 patents)
2. Blueprint Medicines Corporation (17 from 60 patents)
40 patents:
1. 12172983 - EGFR inhibitors
2. 11827642 - Compositions useful for treating disorders related to KIT
3. 11718602 - EGFR inhibitors
4. 11634422 - Inhibitors of activin receptor-like kinase
5. 11279688 - Inhibitors of RET
6. 11040979 - Substituted pyrrolo[1,2-b]pyridazines for treating disorders related to KIT and PDGFR
7. 10807985 - Compositions useful for treating disorders related to kit
8. 10759805 - Compounds that are ERK inhibitors
9. 10669277 - Inhibitors of activin receptor-like kinase
10. 10584114 - Inhibitors of RET
11. 10233186 - Inhibitors of activin receptor-like kinase
12. 10227329 - Compounds useful for treating disorders related to RET
13. 10183928 - Inhibitors of RET
14. 10065967 - Compounds that are ERK inhibitors
15. 10030005 - Inhibitors of RET